Course Credit: 1 hour
Learning Objectives
- Distinguish mechanistic differences between anticoagulation and thrombolysis
- Explain treatment options for DVT and PE
- Optimize treatment selection based upon patient and medication specific variables
- Design anticoagulation regimens for special populations
Course Content
Introduction: Pharmacology of VTE
You don't currently have access to this content
Anticoagulation Options for VTE
You don't currently have access to this content
Special Populations
You don't currently have access to this content
Hemodynamically Unstable PE Management
You don't currently have access to this content
Pharmacology of Venous Thromboemolism | Quiz
You don't currently have access to this content
Thank you
Why the 100 mg bolus for code dose of tpa in that question when none of the studies listed evaluated a 100mg push?
Hi Tyler: Excellent point and thanks for catching our oversight. We fixed it in the answer option.
Regarding the reference to 11% of patients dying within 1 hour secondary to acute PE, are we talking about massive PE here specifically?
Daryl, Thanks so much for utilizing Capsules! The 11% is really a rough estimate based on estimated annual incidence of PE. Since these patients are unable to be studied (they never present for treatment) it is assumed death is due to massive PE. Thanks again for your interest in Capsules!